1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Chronic Disease Analysis & Statistics 2021 - Europe (p2)

Chronic Disease Analysis & Statistics 2021 - Europe (p2)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct

All regions

31-45 of 35 reports

Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 152 pages

Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H2 2019 Summary Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Recepto ...

  • World
  • Poland
  • Therapy
  • Chronic Pain
  • Industry analysis
  • Drug Approval
  • Mortality Rate

Midkine - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 43 pages

Midkine - Pipeline Review, H2 2019 Summary Midkine (Amphiregulin Associated Protein or Midgestation And Kidney Protein or Neurite Outgrowth Promoting Factor 2 or MDK) pipeline Target constitutes close ...

  • World
  • Europe
  • Lung Cancer
  • Brain Cancer
  • Industry analysis

NADPH Oxidase 4 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 65 pages

NADPH Oxidase 4 - Pipeline Review, H2 2019 Summary According to the recently published report ’NADPH Oxidase 4 - Pipeline Review, H2 2019’; NADPH Oxidase 4 (Kidney Oxidase 1 or KOX1 or Kidney Superoxide ...

  • World
  • Netherlands
  • Stroke
  • Diabetes
  • Industry analysis
  • Drug Approval

Bronchitis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019
  • 129 pages

Bronchitis - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bronchitis - Pipeline Review, H2 2019, provides an overview of the Bronchitis (Respiratory) ...

  • World
  • European Union
  • Therapy
  • Respiratory Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2019

  • $ 3500
  • March 2019
  • 96 pages

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) ...

  • World
  • United States
  • Therapy
  • Musculoskeletal Disorder
  • Industry analysis
  • Drug Approval
  • Health Provider Density

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2018

  • $ 3500
  • October 2018
  • 53 pages

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H2 2018 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide ...

  • World
  • Northern Europe
  • Type 2 Diabetes
  • Diabetes
  • Industry analysis
  • Food Consumption
  • Diabetes Prevalence

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 57 pages

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H2 2018 Summary According to the recently published report ’Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 ...

  • World
  • Europe
  • Clinical Trial
  • Arthritis
  • Industry analysis
  • Surgical Procedures Performed
  • Outpatient Visits

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2018

  • $ 3500
  • April 2018
  • 49 pages

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Pipeline Review, H1 2018 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide ...

  • World
  • Northern Europe
  • Type 2 Diabetes
  • Diabetes
  • Industry analysis
  • Food Consumption
  • Prescription Drug Sales

Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1) - Pipeline Review, H2 2017

  • $ 3500
  • December 2017
  • 48 pages

Interleukin 1 Receptor Type 1 (CD121 Antigen Like Family Member A or Interleukin 1 Receptor Alpha or p80 or CD121a or IL1R1) - Pipeline Review, H2 2017 Summary Interleukin 1 Receptor Type 1 (CD121 Antigen ...

  • World
  • Sweden
  • Protein Therapy
  • Arthritis
  • Industry analysis

Allergic Asthma - Pipeline Review, H2 2016

  • $ 2000
  • August 2016
  • 181 pages

Allergic Asthma - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Allergic Asthma - Pipeline Review, H2 2016’, provides an overview of the Allergic Asthma pipeline landscape. The ...

  • World
  • Italy
  • Asthma
  • Industry analysis
  • Medicine Use
  • Drug Approval

Transient Receptor Potential Cation Channel Subfamily A Member 1 (Ankyrin Like With Transmembrane Domains Protein 1 or Transformation Sensitive Protein p120 or TRPA1) - Pipeline Review, H2 2016

  • $ 3500
  • July 2016
  • 64 pages

Transient Receptor Potential Cation Channel Subfamily A Member 1 (Ankyrin Like With Transmembrane Domains Protein 1 or Transformation Sensitive Protein p120 or TRPA1) - Pipeline Review, H2 2016 Summary Global ...

  • World
  • Poland
  • Neurological Disorder
  • Pharmaceutical
  • Industry analysis

Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) - Pipeline Review, H1 2016

  • $ 3500
  • May 2016
  • 65 pages

Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) - Pipeline Review, H1 2016’, provides ...

  • World
  • European Union
  • Drug Development
  • Chronic Pain
  • Industry analysis
  • Prescription Drug Sales
  • Drug Approval

Portal Hypertension - Pipeline Review, H1 2016

  • $ 2000
  • March 2016
  • 73 pages

Portal Hypertension - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Portal Hypertension - Pipeline Review, H1 2016’, provides an overview of the Portal Hypertension pipeline landscape. ...

  • World
  • European Union
  • Hypertension
  • Research And Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Health Provider Density

Allergic Asthma - Pipeline Review, H1 2016

  • $ 2000
  • February 2016
  • 182 pages

Allergic Asthma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Allergic Asthma - Pipeline Review, H1 2016’, provides an overview of the Allergic Asthma pipeline landscape. The ...

  • World
  • Italy
  • Asthma
  • Industry analysis
  • Medicine Use
  • Drug Approval

Heptares Therapeutics Limited - Product Pipeline Review - 2016

  • $ 1500
  • February 2016
  • 45 pages

Heptares Therapeutics Limited - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Heptares Therapeutics Limited - Product Pipeline Review - 2016’, provides an overview of the ...

  • World
  • United Kingdom
  • Therapy
  • Mental Health
  • Industry analysis
About 5900 reports

Download Unlimited Documents from Trusted Public Sources

View report >

Respiratory Disease Demographic Impact in Wales (UK)

  • October 2021
  • 9 pages
  • Wales
  • Influenza
  • Respiratory Disease
  • Industry analysis
  • Vaccination Coverage
  • Practising Nurses And Midwives

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on